Free previewYou're reading the free part of this topic. The rest is included with Clinical.See what's included
Microcornea Nanophthalmos
Cornea
1. Clinical Analogy & Orientation
Exam pearl
- The Pressure Cooker Analogy
- Imagine a pressure cooker (the eye) that is too small for its contents - the contents crowd the eye, and the configuration predisposes to angle closure and surgical complications.
- the walls are abnormally thick and may impede venous or transscleral fluid drainage, the valve (angle) is too crowded to open, and any attempt to release steam (surgery) carries a substantially increased risk of serious complications, including uveal effusion.
- This is nanophthalmos in a nutshell. The eye results from growth arrest after closure of the embryonic fissure - too small in all dimensions - yet the lens is relatively large for the small globe.
- The result is a biological pressure cooker: thick rigid sclera, crowded angle, shallow anterior chamber, and a propensity for uveal effusion, which may occur spontaneously or after surgery.
- Microcornea, by contrast, is like a house with a smaller-than-normal front door - the house (globe) may otherwise be normal in size, but this should be confirmed by biometry. The smaller anterior segment is associated with an increased risk of glaucoma, particularly angle closure.
THE SPECTRUM OF SMALL EYE CONDITIONS - Conceptual Framework
• Small eye anomalies form a spectrum defined by the affected ocular dimensions and whether reduction is global or limited to the anterior or posterior segment. • The key to understanding them is knowing which dimensions are affected and whether the globe itself is small. • The three cardinal entities are:
| Entity | Corneal Diameter | Axial Length | Globe Size | Key Mechanism |
|---|---|---|---|---|
| Microcornea | • < 10 millimetres (mm) (adult) • < 9 millimetres (mm) (newborn) | • Normal (approximately 23–25 millimetres (mm)) | • NORMAL globe | • Arrested or reduced corneal development • The globe may otherwise be normal, but associated ocular anomalies can occur. |
| Nanophthalmos (True) | • Small • Microcornea may be present; < 11 millimetres (mm) | • < 20–20.5 millimetres (mm) • Reported values vary; approximately 14.5–20.5 millimetres (mm) in one large clinical series | • Uniformly SMALL | • Developmental underdevelopment of the anterior and posterior segments with abnormally thickened sclera |
| Relative anterior microphthalmos (RAM) | • ≤ 11 millimetres (mm) | • Normal | • Normal posterior segment | • Disproportionately small anterior segment with normal axial length and no other ocular anatomical malformations. |
| Simple Microphthalmos (Clinical) | • Variable | • Shorter than the age-adjusted mean by two standard deviations, typically < 21.0 millimetres (mm). | • Small without anatomical malformations • Coloboma or other structural anomalies indicate complex microphthalmos. | • Short axial length with normal anterior chamber depth and scleral thickness, without anatomical malformations • Associated structural defects indicate complex microphthalmos. |
| Phthisis bulbi | • Very small | • No fixed axial-length criterion | • A shrunken, atrophic globe with intraocular disorganization | • End-stage degeneration |
| Entity | Corneal Diameter | Axial Length | Globe Size | Key Mechanism |
|---|---|---|---|---|
| Microcornea | • < 10 millimetres (mm) (adult) • < 9 millimetres (mm) (newborn) | • Normal (approximately 23–25 millimetres (mm)) | • NORMAL globe | • Arrested or reduced corneal development • The globe may otherwise be normal, but associated ocular anomalies can occur. |
| Nanophthalmos (True) | • Small • Microcornea may be present; < 11 millimetres (mm) | • < 20–20.5 millimetres (mm) • Reported values vary; approximately 14.5–20.5 millimetres (mm) in one large clinical series | • Uniformly SMALL | • Developmental underdevelopment of the anterior and posterior segments with abnormally thickened sclera |
| Relative anterior microphthalmos (RAM) | • ≤ 11 millimetres (mm) | • Normal | • Normal posterior segment | • Disproportionately small anterior segment with normal axial length and no other ocular anatomical malformations. |
| Simple Microphthalmos (Clinical) | • Variable | • Shorter than the age-adjusted mean by two standard deviations, typically < 21.0 millimetres (mm). | • Small without anatomical malformations • Coloboma or other structural anomalies indicate complex microphthalmos. | • Short axial length with normal anterior chamber depth and scleral thickness, without anatomical malformations • Associated structural defects indicate complex microphthalmos. |
| Phthisis bulbi | • Very small | • No fixed axial-length criterion | • A shrunken, atrophic globe with intraocular disorganization | • End-stage degeneration |
Exam pearl
- Relative anterior microphthalmos (RAM) = a small-anterior-segment phenotype with normal axial length and a small corneal diameter; it carries increased glaucoma, particularly angle-closure, risk. Reviews report a similar incidence of angle-closure glaucoma to nanophthalmos, although direct comparative risk estimates are limited.
- A small cornea, shallow anterior chamber and high hyperopia should prompt biometric evaluation for nanophthalmos, relative anterior microphthalmos (RAM) and other small-eye phenotypes; the triad alone is not diagnostic.
2. Embryology & Pathophysiology
Normal Ocular Embryogenesis - Relevant Milestones
- The eye develops from four major primordial sources: neuroectoderm (optic vesicle → cup), surface ectoderm (lens, corneal epithelium), neural crest–derived mesenchyme (corneal stroma/endothelium, trabecular meshwork, uveal stroma, sclera), and mesoderm.
- Disruption at any stage produces a spectrum of anomalies proportional to the timing of insult.
| Week | Event | Arrested Development → Anomaly |
|---|---|---|
| Week 4–5 | • Optic vesicle invaginates → optic cup | • Failure of optic-vesicle development/evagination → anophthalmos or severe microphthalmos |
| Week 5–6 | • Lens vesicle separates from surface ectoderm | • Failure of lens induction → primary congenital aphakia • Failed separation → persistent lens stalk or ectodermal connection |
| Week 6–7 | • Closure of embryonic (choroidal) fissure | • Failure → coloboma |
| Week 6–8 | • Neural crest migration into anterior segment | • Disruption of neural crest-derived anterior-segment development → Axenfeld-Rieger spectrum, Peters anomaly |
| Week 8–12 | • Bowman’s layer formation | • Partial arrest → corneal dysgenesis, microcornea |
| Week 12–20 | • Corneal epithelial stratification | • Partial arrest → corneal dysgenesis, microcornea |
| Begins around Week 7 and continues through fetal development | • Scleral development from para-ocular neural crest-derived mesenchyme | • Abnormal scleral collagen organization and fibril morphology are associated with the thick sclera of nanophthalmos |
| Prenatal development and postnatal period | • Ocular axial growth occurs during prenatal development and continues postnatally | • Arrest of ocular growth → nanophthalmos; corneal size may be normal |
| Week | Event | Arrested Development → Anomaly |
|---|---|---|
| Week 4–5 | • Optic vesicle invaginates → optic cup | • Failure of optic-vesicle development/evagination → anophthalmos or severe microphthalmos |
| Week 5–6 | • Lens vesicle separates from surface ectoderm | • Failure of lens induction → primary congenital aphakia • Failed separation → persistent lens stalk or ectodermal connection |
| Week 6–7 | • Closure of embryonic (choroidal) fissure | • Failure → coloboma |
| Week 6–8 | • Neural crest migration into anterior segment | • Disruption of neural crest-derived anterior-segment development → Axenfeld-Rieger spectrum, Peters anomaly |
| Week 8–12 | • Bowman’s layer formation | • Partial arrest → corneal dysgenesis, microcornea |
| Week 12–20 | • Corneal epithelial stratification | • Partial arrest → corneal dysgenesis, microcornea |
| Begins around Week 7 and continues through fetal development | • Scleral development from para-ocular neural crest-derived mesenchyme | • Abnormal scleral collagen organization and fibril morphology are associated with the thick sclera of nanophthalmos |
| Prenatal development and postnatal period | • Ocular axial growth occurs during prenatal development and continues postnatally | • Arrest of ocular growth → nanophthalmos; corneal size may be normal |
Pathophysiology of Nanophthalmos - Molecular & Structural Basis
- A. Genetic Underpinnings
- Nanophthalmos is primarily genetic; sporadic cases exist but are less common:
- Membrane Frizzled-Related Protein (MFRP) - chromosome 11q23; autosomal-recessive nanophthalmos. MFRP loss is associated with reduced ocular axial growth and nanophthalmos; nanophthalmos commonly features a thickened ocular wall and sclera.
- PRSS56 - chromosome 2q37; autosomal-recessive nanophthalmos with extreme hyperopia, reported in the nanophthalmos spectrum up to approximately +25 diopters; a retinal growth signal involved in axial-growth signaling. Müller glia-specific inactivation reduces axial length and causes hyperopia.
- Vitelliform macular dystrophy 2 (VMD2; Bestrophin-1 [BEST1]) - associated with bestrophinopathies; inheritance may be autosomal dominant or autosomal recessive depending on the phenotype. Autosomal-dominant vitreoretinochoroidopathy can have a nanophthalmos-like phenotype. Bestrophin-1 is a calcium-activated chloride channel in the basolateral membrane of the retinal pigment epithelium.
- Complement C1q and tumor necrosis factor-related protein 5 (C1QTNF5; C1QTNF5-related protein 5 [CTRP5]) - Late-onset retinal degeneration.
- Transmembrane protein 98 (TMEM98) - autosomal-dominant nanophthalmos; transmembrane protein that interacts with myelin regulatory factor (MYRF) and participates in regulation of MYRF activity.
- Myelin Regulatory Factor (MYRF) - MYRF variants are associated with autosomal-dominant nanophthalmos and, in some cases, syndromic manifestations; a membrane-associated transcription factor involved in oligodendrocyte differentiation and myelination.
B. Scleral Pathology - The Central Mechanical Problem
An associated histopathological abnormality in nanophthalmos includes abnormal, irregularly arranged scleral collagen fibrils. Excessive collagen crosslinking and proteoglycan deposition remain unverified in the completed evidence.
- Markedly thickened sclera; the specific claim of 3–5× normal thickness is unverified.
- Nanophthalmos results from developmental arrest or compromised ocular growth; abnormal scleral collagen architecture may contribute to scleral inelasticity, impaired transscleral protein and glycosaminoglycan outflow, and impaired vortex-vein drainage.
- Thickened or abnormal sclera may compress the vortex veins, impairing uveal or choroidal venous drainage.
- Vortex vein compression → uveal congestion; the direct causal link to transudate accumulation in the suprachoroidal space remains uncertain → uveal effusion / ciliochoroidal detachment.
- Suprachoroidal effusion → anterior rotation of ciliary body → shallowing of anterior chamber → secondary angle-closure glaucoma
Pathogenic Cascade in Nanophthalmos
0 decision points · select a node or explore one route
Select a node to review its supporting details.
Pathogenic Cascade in Nanophthalmos
View the complete algorithm or study one route
Tap a node for details
Free preview ends here
Keep reading Microcornea Nanophthalmos
10 more sections are included with the Clinical plan.
- Microcornea: Detailed Review
- Nanophthalmos
- Investigations
- Management
- High-Yield Comparison Table
- Emerging Concepts & Evolving Evidence